Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|May 1, 2020
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of ViewManuela Labbozzetta, Monica Notarbartolo, Paola Poma
Critical Reviews in Oncogenesis|August 4, 2021
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome ItPaola Poma, Manuela Labbozzetta, Monica Notarbartolo
International Journal of Molecular Sciences|February 25, 2023
Natural Inhibitors of P-glycoprotein in Acute Myeloid LeukemiaManuela Labbozzetta, Paola Poma, Monica Notarbartolo
Omics : a Journal of Integrative Biology|April 8, 2017
NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast CancersPaola Poma, Manuela Labbozzetta, Natale D'Alessandro, et al.
Current Molecular Medicine|January 5, 2019
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver CarcinomaMonica Notarbartolo, Manuela Labbozzetta, Fanny Pojero, et al.
Omics : a Journal of Integrative Biology|October 26, 2012
Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinomaPaola Poma, Manuela Labbozzetta, Nicoletta Vivona, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid LeukemiaManuela Labbozzetta, Paola Poma, Marco Tutone, et al.
Pageof 4